DoD Drug Demand Reduction Program PED and Steroid Testing - Sole Source Notice
Closed Solicitation Posted
- Solicitation number
- N0018925RZ094
- Agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- South Jordan, Utah 84095, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Navy Naval Supply Systems Command is seeking laboratory testing services for anabolic steroids and performance-enhancing drugs (PEDs) in support of the DoD Drug Demand Reduction Program (DDRP). The contractor must provide comprehensive testing of human urine specimens according to World Anti-Doping Agency Code (WADAC) and DoD specifications, focusing on substances listed in Classes S1, S2, and S4 of the World Anti-Doping Code Prohibited List. The selected laboratory must be WADA-accredited, maintain strict forensic and scientific standards, conduct both confirmatory and isotope ratio mass spectrometry (IRMS) testing, and deliver results within 7-10 business days while maintaining proper chain of custody procedures. This is a sole-source procurement with evaluation based on the contractor's ability to meet these specialized requirements and maintain WADA accreditation. The solicitation was posted on August 22, 2025, with responses due by August 25, 2025.
This procurement is designated as a sole-source award with no set-aside provisions, targeting the Sports Medicine Research and Testing Laboratory (SMRTL) as the incumbent and recommended contractor. The contract structure is an Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with a three-year performance period from August 24, 2025, through August 23, 2028, carrying a ceiling value of $12,078,900.00. The laboratory must be capable of conducting up to 19,000 initial PED tests and 1,140 IRMS tests annually, with a minimum guaranteed order of 5 tests, and provide 40 hours of expert telephonic consultation services. Work will be performed in the continental United States, specifically at the contractor's facility in Riverton, Utah, with multiple Navy drug screening laboratories authorized to place delivery orders. The contract will be initially funded with $3,999,970.00 in FY 2025 Operation & Maintenance, Navy funding from the Navy and Marine Corps Force Health Protection Command.
Notice text
This is a solicitation for laboratory testing in the continental United States
(CONUS) for steroid and performance-enhancing drugs in support of the
DoD Drug Demand Reduction Program (DDRP). The contractor shall
furnish all labor, equipment, materials, and facilities to perform anabolic
steroid and other Performance Enhancing Drugs (PEDs) explicitly listed in
Classes S1, S2 and S4 of the World Anti-Doping Code Prohibited List testing
on human urine specimens under the forensic and scientific specifications
of the WADAC and the DOD DDRP Instructions.
The Justification and Authority to solicit on a sole-source basis is attached
to this notice.
Files
| File | Type | Posted |
|---|---|---|
| JA 25-184 - DDRP PED testing_30JULY2025_NMCFHPC.pdf | ||
| N0018925RZ094 Amend 01 - DDRP PED testing.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| DoD Drug Demand Reduction Program PED and Steroid Testing - Sole Source Notice | Pre-Solicitation | |
| Performance Enhancing Drug Testing for Navy Drug Demand Reduction Program (DDRP) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity